e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Asthma: outcomes of clinical trials and cohorts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of urea as a normalization factor for nasosorption samples
V. Steffen (South San Francisco, United States of America), F. Cai (South San Francisco, United States of America), T. Staton (South San Francisco, United States of America), M. Bremer (South San Francisco, United States of America), P. Banerjee (South San Francisco, United States of America), R. Bauer (South San Francisco, United States of America)
Source:
International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Session:
Asthma: outcomes of clinical trials and cohorts
Session type:
Thematic Poster
Number:
4256
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Steffen (South San Francisco, United States of America), F. Cai (South San Francisco, United States of America), T. Staton (South San Francisco, United States of America), M. Bremer (South San Francisco, United States of America), P. Banerjee (South San Francisco, United States of America), R. Bauer (South San Francisco, United States of America). Evaluation of urea as a normalization factor for nasosorption samples. 4256
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Validation of the standard deviation of haematocrit as a measure of homogeneity of the sample in blood gas syringes
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
Determination of blood leukocyte concentration with constant time acquisition volume is comparable with individualized analysis with beads as internal reference standard
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Rapid DNA extraction from dried blood spots for the alpha-1 antitrypsin deficiency detection by real-time PCR
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Blood lactate level in patients with severe COVID-19: Does it have any added value?
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004
High levels of serum cholesterol – protective and predictive factor for activation of tuberculosis; practical considerations
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Long-term effect of hepatocyte growth factor in the normal lung: A stereological assessment
Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Year: 2011
Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Matrix metalloproteinase-9 (MMP-9) and transforming growth factor β1 (TGF β1) levels in induced sputum and serum samples of mild and severe asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001
Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre
Source: International Congress 2017 – Rare diseases
Year: 2017
Plasma protein profiling in alpha-1-antitrypsin deficiency
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Plasma stromal derived factor 1 alpha levels in pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 141s
Year: 2006
Accurate and reliable determination of alpha1-antitrypsin levels in respiratory patients using dried blood spot specimens
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Glomerular filtration rate is a confounder for determination of serum soluble mesothelin
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Plasma circulating miRNAs as diagnostic and prognostic biomarkers in alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Comparison of physical and biochemical variables of EBC samples
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005
Genomic DNA extraction from small amounts of serum to be used for α1-antitrypsin genotype analysis.
Source: Eur Respir J 2003; 21: 911
Year: 2003
Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
The prognostic value of increased blood urea nitrogen in pulmonary hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept